NLM Logo

naquotinib MeSH Supplementary Concept Data 2025


MeSH Supplementary
naquotinib
Unique ID
C000627869
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000627869
Entry Term(s)
ASP-8273
ASP8273
Pharm Action
Antineoplastic Agents
Protein Kinase Inhibitors
Registry Numbers
47DD4548PB
Heading Mapped to
*Piperazines
*Piperidines
*Pyrazines
*Pyrrolidines
Frequency
8
Note
a third-generation EGFR tyrosine kinase inhibitor (TKI) for the treatment of non-small cell lung cancer (NSCLC) in patients with EGFR mutations
Source
Clin Cancer Res. 2017 Dec 15;23(24):7467-7473.
Date of Entry
2018/08/07
Revision Date
2018/08/07
naquotinib Preferred
ASP8273 Narrower
page delivered in 0.004s